The U.S. Food and Drug Administration has approved a single shared Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) products. This new system will replace…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.